
<AdverseEventReport>
	<id>79</id>
	<createdAt xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">2009-02-23 11:30:19.916</createdAt>
	<status xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">PENDING</status>
	<AdverseEventResponseDescription>
		<eventDescription>test</eventDescription>
		<presentStatus xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">RECOVERING</presentStatus>
		<retreated>false</retreated>
		<autopsyPerformed>false</autopsyPerformed>
		<primaryTreatmentApproximateTime>
			<type>0</type>
		</primaryTreatmentApproximateTime>
	</AdverseEventResponseDescription>
	<Physician>
		<firstName>Judith</firstName>
		<lastName>Karp</lastName>
		<address/>
		<ContactMechanism xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:org.exolab.castor.mapping.MapItem">
			<key xsi:type="java:java.lang.String">phone</key>
			<value xsi:type="java:java.lang.String">(000)000-0000</value>
		</ContactMechanism>
		<ContactMechanism xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:org.exolab.castor.mapping.MapItem">
			<key xsi:type="java:java.lang.String">e-mail</key>
			<value xsi:type="java:java.lang.String">default@abc.com</value>
		</ContactMechanism>
	</Physician>
	<Reporter>
		<firstName>Judith</firstName>
		<lastName>Karp</lastName>
		<address/>
		<ContactMechanism xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:org.exolab.castor.mapping.MapItem">
			<key xsi:type="java:java.lang.String">phone</key>
			<value xsi:type="java:java.lang.String">(000)000-0000</value>
		</ContactMechanism>
		<ContactMechanism xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:org.exolab.castor.mapping.MapItem">
			<key xsi:type="java:java.lang.String">fax</key>
			<value xsi:type="java:java.lang.String">(000)000-0000</value>
		</ContactMechanism>
		<ContactMechanism xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:org.exolab.castor.mapping.MapItem">
			<key xsi:type="java:java.lang.String">e-mail</key>
			<value xsi:type="java:java.lang.String">default@abc.com</value>
		</ContactMechanism>
	</Reporter>
	<DiseaseHistory>
		<diagnosisDate>
			<monthString>10</monthString>
			<yearString>2006</yearString>
		</diagnosisDate>
		<CtepStudyDisease>
			<id>57</id>
			<leadDisease>false</leadDisease>
			<DiseaseTerm>
				<id>204</id>
				<term>Primary peritoneal carcinoma</term>
				<ctepTerm>Primary peritoneal carcinoma</ctepTerm>
				<DiseaseCategory>
					<id>104</id>
					<name>Ovarian Cancer (excluding Ovarian Germ Cell Cancer)</name>
				</DiseaseCategory>
			</DiseaseTerm>
		</CtepStudyDisease>
		<AnatomicSite>
			<id>39</id>
			<name>Ovary</name>
			<category>Genitourinary</category>
		</AnatomicSite>
	</DiseaseHistory>
	<ParticipantHistory>
		<height>
			<quantity>150</quantity>
			<unit>Centimeter</unit>
		</height>
		<weight>
			<quantity>100</quantity>
			<unit>Kilogram</unit>
		</weight>
		<baselinePerformanceStatus>0 = Normal Activity, asymptomatic</baselinePerformanceStatus>
	</ParticipantHistory>
	<StudyParticipantAssignment>
		<dateOfEnrollment>2009-02-23T00:00:00.000-05:00</dateOfEnrollment>
		<StudySite>
			<StudyInvestigator>
				<id>195</id>
				<roleCode>Site Investigator</roleCode>
				<statusCode>Active</statusCode>
				<SiteInvestigator>
					<id>75</id>
					<Investigator>
						<id>30071</id>
						<firstName>Ross</firstName>
						<lastName>Donehower</lastName>
						<nciIdentifier>9973</nciIdentifier>
						<emailAddress>default@abc.com</emailAddress>
						<phoneNumber>(000)000-0000</phoneNumber>
						<faxNumber>(000)000-0000</faxNumber>
					</Investigator>
				</SiteInvestigator>
			</StudyInvestigator>
			<StudyInvestigator>
				<id>169</id>
				<roleCode>Site Investigator</roleCode>
				<statusCode>Active</statusCode>
				<SiteInvestigator>
					<id>19</id>
					<Investigator>
						<id>30019</id>
						<firstName>Manuel</firstName>
						<lastName>Hidalgo</lastName>
						<nciIdentifier>26783</nciIdentifier>
						<emailAddress>default@abc.com</emailAddress>
						<phoneNumber>(000)000-0000</phoneNumber>
						<faxNumber>(000)000-0000</faxNumber>
					</Investigator>
				</SiteInvestigator>
			</StudyInvestigator>
			<Study>
				<id>22</id>
				<multiInstitutionIndicator>true</multiInstitutionIndicator>
				<shortTitle>Phase II Trial of Flavopiridol and Cisplatin in Advanced Epithelial Ovarian and Primary Peritoneal Carcinomas</shortTitle>
				<longTitle>Phase II Trial of Flavopiridol and Cisplatin in Advanced Epithelial Ovarian and Primary Peritoneal Carcinomas</longTitle>
				<description>Phase II Trial of Flavopiridol and Cisplatin in Advanced Epithelial Ovarian and Primary Peritoneal Carcinomas</description>
				<phaseCode>Phase II Trial</phaseCode>
				<primarySponsorCode>CTEP</primarySponsorCode>
				<status>Active - Trial is open to accrual</status>
				<Ctc>
					<id>3</id>
					<name>CTCAE v3.0</name>
				</Ctc>
				<Identifier>
					<type>Protocol Authority Identifier</type>
					<value>5876</value>
					<primaryIndicator>true</primaryIndicator>
				</Identifier>
				<Identifier>
					<type>Coordinating Center Identifier</type>
					<value>MC0261</value>
					<primaryIndicator>false</primaryIndicator>
				</Identifier>
				<StudyAgent>
					<Agent>
						<id>443</id>
						<name>Alvocidib (flavopiridol)</name>
						<nscNumber>649890</nscNumber>
					</Agent>
					<INDType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">CTEP_IND</INDType>
				</StudyAgent>
				<StudyAgent>
					<Agent>
						<id>240</id>
						<name>CISplatin</name>
						<nscNumber>119875</nscNumber>
					</Agent>
					<INDType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">NA_COMMERCIAL</INDType>
				</StudyAgent>
				<CtepStudyDisease>
					<id>56</id>
					<leadDisease>true</leadDisease>
					<DiseaseTerm>
						<id>201</id>
						<term>Ovarian epithelial cancer</term>
						<ctepTerm>Ovarian epithelial cancer</ctepTerm>
						<DiseaseCategory>
							<id>104</id>
							<name>Ovarian Cancer (excluding Ovarian Germ Cell Cancer)</name>
						</DiseaseCategory>
					</DiseaseTerm>
				</CtepStudyDisease>
				<CtepStudyDisease>
					<id>57</id>
					<leadDisease>false</leadDisease>
					<DiseaseTerm>
						<id>204</id>
						<term>Primary peritoneal carcinoma</term>
						<ctepTerm>Primary peritoneal carcinoma</ctepTerm>
						<DiseaseCategory>
							<id>104</id>
							<name>Ovarian Cancer (excluding Ovarian Germ Cell Cancer)</name>
						</DiseaseCategory>
					</DiseaseTerm>
				</CtepStudyDisease>
			</Study>
			<Organization>
				<id>104094</id>
				<name>Johns Hopkins University</name>
				<nciInstituteCode>MD017</nciInstituteCode>
				<SiteInvestigator>
					<id>48</id>
					<Investigator>
						<id>30048</id>
						<firstName>Judith</firstName>
						<lastName>Karp</lastName>
						<nciIdentifier>8140</nciIdentifier>
						<emailAddress>default@abc.com</emailAddress>
						<phoneNumber>(000)000-0000</phoneNumber>
						<faxNumber>(000)000-0000</faxNumber>
					</Investigator>
				</SiteInvestigator>
				<SiteInvestigator>
					<id>60</id>
					<Investigator>
						<id>30057</id>
						<firstName>Steven</firstName>
						<lastName>Gore</lastName>
						<nciIdentifier>15984</nciIdentifier>
						<emailAddress>default@abc.com</emailAddress>
						<phoneNumber>(410) 614-1005</phoneNumber>
						<faxNumber>(410)955-8781</faxNumber>
					</Investigator>
				</SiteInvestigator>
				<SiteInvestigator>
					<id>68</id>
					<Investigator>
						<id>30065</id>
						<firstName>Roberto</firstName>
						<lastName>Pili</lastName>
						<nciIdentifier>31509</nciIdentifier>
						<emailAddress>default@abc.com</emailAddress>
						<phoneNumber>(000)000-0000</phoneNumber>
						<faxNumber>(000)000-0000</faxNumber>
					</Investigator>
				</SiteInvestigator>
				<SiteInvestigator>
					<id>75</id>
					<Investigator>
						<id>30071</id>
						<firstName>Ross</firstName>
						<lastName>Donehower</lastName>
						<nciIdentifier>9973</nciIdentifier>
						<emailAddress>default@abc.com</emailAddress>
						<phoneNumber>(000)000-0000</phoneNumber>
						<faxNumber>(000)000-0000</faxNumber>
					</Investigator>
				</SiteInvestigator>
				<SiteInvestigator>
					<id>19</id>
					<Investigator>
						<id>30019</id>
						<firstName>Manuel</firstName>
						<lastName>Hidalgo</lastName>
						<nciIdentifier>26783</nciIdentifier>
						<emailAddress>default@abc.com</emailAddress>
						<phoneNumber>(000)000-0000</phoneNumber>
						<faxNumber>(000)000-0000</faxNumber>
					</Investigator>
				</SiteInvestigator>
			</Organization>
		</StudySite>
		<Participant>
			<firstName>Pat</firstName>
			<lastName>Little</lastName>
			<dateOfBirth>
				<dayString>12</dayString>
				<monthString>12</monthString>
				<yearString>1940</yearString>
			</dateOfBirth>
			<gender>Female</gender>
			<race>Unknown</race>
			<ethnicity>Unknown</ethnicity>
			<Identifier>
				<type>CC</type>
				<value>PL-113</value>
				<primaryIndicator>true</primaryIndicator>
			</Identifier>
		</Participant>
		<studySubjectIdentifier>PL-113</studySubjectIdentifier>
	</StudyParticipantAssignment>
	<AdverseEvent>
		<gridId>PRY1962e8f6-aa73-40ac-94e6-af6ebcfd9619</gridId>
		<startDate>2009-03-02T00:00:00.000-05:00</startDate>
		<CourseAgentAttribution>
			<id>289</id>
			<attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">3: Possible</attribution>
			<CourseAgent>
				<id>82</id>
				<lastAdministeredDate>2008-12-01T00:00:00.000-05:00</lastAdministeredDate>
				<Dose>
					<amount>100</amount>
					<units>mg</units>
				</Dose>
				<StudyAgent>
					<Agent>
						<id>443</id>
						<name>Alvocidib (flavopiridol)</name>
						<nscNumber>649890</nscNumber>
					</Agent>
					<INDType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">CTEP_IND</INDType>
				</StudyAgent>
			</CourseAgent>
		</CourseAgentAttribution>
		<CourseAgentAttribution>
			<id>299</id>
			<attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">3: Possible</attribution>
			<CourseAgent>
				<id>83</id>
				<lastAdministeredDate>2008-12-04T00:00:00.000-05:00</lastAdministeredDate>
				<Dose>
					<amount>60</amount>
					<units>mg</units>
				</Dose>
				<StudyAgent>
					<Agent>
						<id>240</id>
						<name>CISplatin</name>
						<nscNumber>119875</nscNumber>
					</Agent>
					<INDType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">NA_COMMERCIAL</INDType>
				</StudyAgent>
			</CourseAgent>
		</CourseAgentAttribution>
		<DiseaseAttribution>
			<id>290</id>
			<attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">2: Unlikely</attribution>
			<DiseaseHistory>
				<id>79</id>
				<diagnosisDate>
					<monthString>10</monthString>
					<yearString>2006</yearString>
				</diagnosisDate>
				<CtepStudyDisease>
					<id>57</id>
					<leadDisease>false</leadDisease>
					<DiseaseTerm>
						<id>204</id>
						<term>Primary peritoneal carcinoma</term>
						<ctepTerm>Primary peritoneal carcinoma</ctepTerm>
						<DiseaseCategory>
							<id>104</id>
							<name>Ovarian Cancer (excluding Ovarian Germ Cell Cancer)</name>
						</DiseaseCategory>
					</DiseaseTerm>
				</CtepStudyDisease>
				<AnatomicSite>
					<id>39</id>
					<name>Ovary</name>
					<category>Genitourinary</category>
				</AnatomicSite>
			</DiseaseHistory>
		</DiseaseAttribution>
		<AdverseEventCtcTerm other-required="false" med-dRA="false">
			<ctc-term>
				<id>3101</id>
				<term>Dry skin</term>
				<ctepTerm>Dry skin</ctepTerm>
				<ctepCode>10013786</ctepCode>
				<otherRequired>false</otherRequired>
				<CtcCategory>
					<id>309</id>
					<name>DERMATOLOGY/SKIN</name>
				</CtcCategory>
			</ctc-term>
			<universal-term>Dry skin</universal-term>
			<term xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="CtcTerm">
				<id>3101</id>
				<term>Dry skin</term>
				<ctepTerm>Dry skin</ctepTerm>
				<ctepCode>10013786</ctepCode>
				<otherRequired>false</otherRequired>
				<CtcCategory>
					<id>309</id>
					<name>DERMATOLOGY/SKIN</name>
				</CtcCategory>
			</term>
			<full-name>Dry skin</full-name>
		</AdverseEventCtcTerm>
		<AdverseEventMeddraLowLevelTerm/>
		<attributionSummary xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">3: Possible</attributionSummary>
		<grade xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">3: Severe</grade>
		<hospitalization xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">1: Yes</hospitalization>
		<eventApproximateTime>
			<type>0</type>
		</eventApproximateTime>
		<Outcome>
			<id>259</id>
			<OutcomeType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">HOSPITALIZATION</OutcomeType>
		</Outcome>
	</AdverseEvent>
	<AdverseEvent>
		<gridId>PRNc0c93f5e-fd4c-4b8f-99c7-0da23dc4edd6</gridId>
		<CourseAgentAttribution>
			<id>291</id>
			<attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">2: Unlikely</attribution>
			<CourseAgent>
				<id>82</id>
				<lastAdministeredDate>2008-12-01T00:00:00.000-05:00</lastAdministeredDate>
				<Dose>
					<amount>100</amount>
					<units>mg</units>
				</Dose>
				<StudyAgent>
					<Agent>
						<id>443</id>
						<name>Alvocidib (flavopiridol)</name>
						<nscNumber>649890</nscNumber>
					</Agent>
					<INDType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">CTEP_IND</INDType>
				</StudyAgent>
			</CourseAgent>
		</CourseAgentAttribution>
		<CourseAgentAttribution>
			<id>300</id>
			<attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">3: Possible</attribution>
			<CourseAgent>
				<id>83</id>
				<lastAdministeredDate>2008-12-04T00:00:00.000-05:00</lastAdministeredDate>
				<Dose>
					<amount>60</amount>
					<units>mg</units>
				</Dose>
				<StudyAgent>
					<Agent>
						<id>240</id>
						<name>CISplatin</name>
						<nscNumber>119875</nscNumber>
					</Agent>
					<INDType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">NA_COMMERCIAL</INDType>
				</StudyAgent>
			</CourseAgent>
		</CourseAgentAttribution>
		<DiseaseAttribution>
			<id>292</id>
			<attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">3: Possible</attribution>
			<DiseaseHistory>
				<id>79</id>
				<diagnosisDate>
					<monthString>10</monthString>
					<yearString>2006</yearString>
				</diagnosisDate>
				<CtepStudyDisease>
					<id>57</id>
					<leadDisease>false</leadDisease>
					<DiseaseTerm>
						<id>204</id>
						<term>Primary peritoneal carcinoma</term>
						<ctepTerm>Primary peritoneal carcinoma</ctepTerm>
						<DiseaseCategory>
							<id>104</id>
							<name>Ovarian Cancer (excluding Ovarian Germ Cell Cancer)</name>
						</DiseaseCategory>
					</DiseaseTerm>
				</CtepStudyDisease>
				<AnatomicSite>
					<id>39</id>
					<name>Ovary</name>
					<category>Genitourinary</category>
				</AnatomicSite>
			</DiseaseHistory>
		</DiseaseAttribution>
		<AdverseEventCtcTerm other-required="false" med-dRA="false">
			<ctc-term>
				<id>3099</id>
				<term>Cheilitis</term>
				<ctepTerm>Cheilitis</ctepTerm>
				<ctepCode>10008417</ctepCode>
				<otherRequired>false</otherRequired>
				<CtcCategory>
					<id>309</id>
					<name>DERMATOLOGY/SKIN</name>
				</CtcCategory>
			</ctc-term>
			<universal-term>Cheilitis</universal-term>
			<term xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="CtcTerm">
				<id>3099</id>
				<term>Cheilitis</term>
				<ctepTerm>Cheilitis</ctepTerm>
				<ctepCode>10008417</ctepCode>
				<otherRequired>false</otherRequired>
				<CtcCategory>
					<id>309</id>
					<name>DERMATOLOGY/SKIN</name>
				</CtcCategory>
			</term>
			<full-name>Cheilitis</full-name>
		</AdverseEventCtcTerm>
		<AdverseEventMeddraLowLevelTerm/>
		<attributionSummary xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">3: Possible</attributionSummary>
		<grade xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">3: Severe</grade>
		<hospitalization xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">1: Yes</hospitalization>
		<eventApproximateTime>
			<type>0</type>
		</eventApproximateTime>
		<Outcome>
			<id>260</id>
			<OutcomeType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">HOSPITALIZATION</OutcomeType>
		</Outcome>
	</AdverseEvent>
	<AdverseEvent>
		<gridId>PRN33dfbffc-fc34-4bbe-8860-3a29a81b8743</gridId>
		<CourseAgentAttribution>
			<id>293</id>
			<attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">3: Possible</attribution>
			<CourseAgent>
				<id>82</id>
				<lastAdministeredDate>2008-12-01T00:00:00.000-05:00</lastAdministeredDate>
				<Dose>
					<amount>100</amount>
					<units>mg</units>
				</Dose>
				<StudyAgent>
					<Agent>
						<id>443</id>
						<name>Alvocidib (flavopiridol)</name>
						<nscNumber>649890</nscNumber>
					</Agent>
					<INDType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">CTEP_IND</INDType>
				</StudyAgent>
			</CourseAgent>
		</CourseAgentAttribution>
		<CourseAgentAttribution>
			<id>301</id>
			<attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">3: Possible</attribution>
			<CourseAgent>
				<id>83</id>
				<lastAdministeredDate>2008-12-04T00:00:00.000-05:00</lastAdministeredDate>
				<Dose>
					<amount>60</amount>
					<units>mg</units>
				</Dose>
				<StudyAgent>
					<Agent>
						<id>240</id>
						<name>CISplatin</name>
						<nscNumber>119875</nscNumber>
					</Agent>
					<INDType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">NA_COMMERCIAL</INDType>
				</StudyAgent>
			</CourseAgent>
		</CourseAgentAttribution>
		<DiseaseAttribution>
			<id>294</id>
			<attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">3: Possible</attribution>
			<DiseaseHistory>
				<id>79</id>
				<diagnosisDate>
					<monthString>10</monthString>
					<yearString>2006</yearString>
				</diagnosisDate>
				<CtepStudyDisease>
					<id>57</id>
					<leadDisease>false</leadDisease>
					<DiseaseTerm>
						<id>204</id>
						<term>Primary peritoneal carcinoma</term>
						<ctepTerm>Primary peritoneal carcinoma</ctepTerm>
						<DiseaseCategory>
							<id>104</id>
							<name>Ovarian Cancer (excluding Ovarian Germ Cell Cancer)</name>
						</DiseaseCategory>
					</DiseaseTerm>
				</CtepStudyDisease>
				<AnatomicSite>
					<id>39</id>
					<name>Ovary</name>
					<category>Genitourinary</category>
				</AnatomicSite>
			</DiseaseHistory>
		</DiseaseAttribution>
		<AdverseEventCtcTerm other-required="false" med-dRA="false">
			<ctc-term>
				<id>3277</id>
				<term>Vomiting</term>
				<ctepTerm>Vomiting</ctepTerm>
				<ctepCode>10047700</ctepCode>
				<otherRequired>false</otherRequired>
				<CtcCategory>
					<id>311</id>
					<name>GASTROINTESTINAL</name>
				</CtcCategory>
			</ctc-term>
			<universal-term>Vomiting</universal-term>
			<term xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="CtcTerm">
				<id>3277</id>
				<term>Vomiting</term>
				<ctepTerm>Vomiting</ctepTerm>
				<ctepCode>10047700</ctepCode>
				<otherRequired>false</otherRequired>
				<CtcCategory>
					<id>311</id>
					<name>GASTROINTESTINAL</name>
				</CtcCategory>
			</term>
			<full-name>Vomiting</full-name>
		</AdverseEventCtcTerm>
		<AdverseEventMeddraLowLevelTerm/>
		<attributionSummary xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">2: Unlikely</attributionSummary>
		<grade xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">2: Moderate</grade>
		<hospitalization xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">2: No</hospitalization>
		<eventApproximateTime>
			<type>0</type>
		</eventApproximateTime>
	</AdverseEvent>
	<AdverseEvent>
		<gridId>PRN80543925-e1ad-4b40-a56e-0bc8f176b52a</gridId>
		<startDate>2008-12-03T00:00:00.000-05:00</startDate>
		<detailsForOther>sick to stomach</detailsForOther>
		<CourseAgentAttribution>
			<id>295</id>
			<attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">3: Possible</attribution>
			<CourseAgent>
				<id>82</id>
				<lastAdministeredDate>2008-12-01T00:00:00.000-05:00</lastAdministeredDate>
				<Dose>
					<amount>100</amount>
					<units>mg</units>
				</Dose>
				<StudyAgent>
					<Agent>
						<id>443</id>
						<name>Alvocidib (flavopiridol)</name>
						<nscNumber>649890</nscNumber>
					</Agent>
					<INDType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">CTEP_IND</INDType>
				</StudyAgent>
			</CourseAgent>
		</CourseAgentAttribution>
		<CourseAgentAttribution>
			<id>302</id>
			<attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">3: Possible</attribution>
			<CourseAgent>
				<id>83</id>
				<lastAdministeredDate>2008-12-04T00:00:00.000-05:00</lastAdministeredDate>
				<Dose>
					<amount>60</amount>
					<units>mg</units>
				</Dose>
				<StudyAgent>
					<Agent>
						<id>240</id>
						<name>CISplatin</name>
						<nscNumber>119875</nscNumber>
					</Agent>
					<INDType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">NA_COMMERCIAL</INDType>
				</StudyAgent>
			</CourseAgent>
		</CourseAgentAttribution>
		<DiseaseAttribution>
			<id>296</id>
			<attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">3: Possible</attribution>
			<DiseaseHistory>
				<id>79</id>
				<diagnosisDate>
					<monthString>10</monthString>
					<yearString>2006</yearString>
				</diagnosisDate>
				<CtepStudyDisease>
					<id>57</id>
					<leadDisease>false</leadDisease>
					<DiseaseTerm>
						<id>204</id>
						<term>Primary peritoneal carcinoma</term>
						<ctepTerm>Primary peritoneal carcinoma</ctepTerm>
						<DiseaseCategory>
							<id>104</id>
							<name>Ovarian Cancer (excluding Ovarian Germ Cell Cancer)</name>
						</DiseaseCategory>
					</DiseaseTerm>
				</CtepStudyDisease>
				<AnatomicSite>
					<id>39</id>
					<name>Ovary</name>
					<category>Genitourinary</category>
				</AnatomicSite>
			</DiseaseHistory>
		</DiseaseAttribution>
		<AdverseEventCtcTerm other-required="false" med-dRA="false">
			<ctc-term>
				<id>3207</id>
				<term>Nausea</term>
				<ctepTerm>Nausea</ctepTerm>
				<ctepCode>10028813</ctepCode>
				<otherRequired>false</otherRequired>
				<CtcCategory>
					<id>311</id>
					<name>GASTROINTESTINAL</name>
				</CtcCategory>
			</ctc-term>
			<universal-term>Nausea: sick to stomach</universal-term>
			<term xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="CtcTerm">
				<id>3207</id>
				<term>Nausea</term>
				<ctepTerm>Nausea</ctepTerm>
				<ctepCode>10028813</ctepCode>
				<otherRequired>false</otherRequired>
				<CtcCategory>
					<id>311</id>
					<name>GASTROINTESTINAL</name>
				</CtcCategory>
			</term>
			<full-name>Nausea</full-name>
		</AdverseEventCtcTerm>
		<AdverseEventMeddraLowLevelTerm/>
		<attributionSummary xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">3: Possible</attributionSummary>
		<grade xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">3: Severe</grade>
		<hospitalization xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">2: No</hospitalization>
		<eventApproximateTime>
			<type>0</type>
		</eventApproximateTime>
	</AdverseEvent>
	<AdverseEvent>
		<gridId>PRNf64bdc95-c659-4a17-8efd-198058d1e227</gridId>
		<CourseAgentAttribution>
			<id>297</id>
			<attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">3: Possible</attribution>
			<CourseAgent>
				<id>82</id>
				<lastAdministeredDate>2008-12-01T00:00:00.000-05:00</lastAdministeredDate>
				<Dose>
					<amount>100</amount>
					<units>mg</units>
				</Dose>
				<StudyAgent>
					<Agent>
						<id>443</id>
						<name>Alvocidib (flavopiridol)</name>
						<nscNumber>649890</nscNumber>
					</Agent>
					<INDType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">CTEP_IND</INDType>
				</StudyAgent>
			</CourseAgent>
		</CourseAgentAttribution>
		<CourseAgentAttribution>
			<id>303</id>
			<attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">3: Possible</attribution>
			<CourseAgent>
				<id>83</id>
				<lastAdministeredDate>2008-12-04T00:00:00.000-05:00</lastAdministeredDate>
				<Dose>
					<amount>60</amount>
					<units>mg</units>
				</Dose>
				<StudyAgent>
					<Agent>
						<id>240</id>
						<name>CISplatin</name>
						<nscNumber>119875</nscNumber>
					</Agent>
					<INDType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">NA_COMMERCIAL</INDType>
				</StudyAgent>
			</CourseAgent>
		</CourseAgentAttribution>
		<DiseaseAttribution>
			<id>298</id>
			<attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">2: Unlikely</attribution>
			<DiseaseHistory>
				<id>79</id>
				<diagnosisDate>
					<monthString>10</monthString>
					<yearString>2006</yearString>
				</diagnosisDate>
				<CtepStudyDisease>
					<id>57</id>
					<leadDisease>false</leadDisease>
					<DiseaseTerm>
						<id>204</id>
						<term>Primary peritoneal carcinoma</term>
						<ctepTerm>Primary peritoneal carcinoma</ctepTerm>
						<DiseaseCategory>
							<id>104</id>
							<name>Ovarian Cancer (excluding Ovarian Germ Cell Cancer)</name>
						</DiseaseCategory>
					</DiseaseTerm>
				</CtepStudyDisease>
				<AnatomicSite>
					<id>39</id>
					<name>Ovary</name>
					<category>Genitourinary</category>
				</AnatomicSite>
			</DiseaseHistory>
		</DiseaseAttribution>
		<AdverseEventCtcTerm other-required="true" med-dRA="false">
			<ctc-term>
				<id>3007</id>
				<term>Auditory/Ear - Other (Specify, __)</term>
				<ctepTerm>Ear disorder</ctepTerm>
				<ctepCode>10014004</ctepCode>
				<otherRequired>true</otherRequired>
				<CtcCategory>
					<id>302</id>
					<name>AUDITORY/EAR</name>
				</CtcCategory>
			</ctc-term>
			<universal-term>Auditory/Ear - Other: Tinnitus</universal-term>
			<term xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="CtcTerm">
				<id>3007</id>
				<term>Auditory/Ear - Other (Specify, __)</term>
				<ctepTerm>Ear disorder</ctepTerm>
				<ctepCode>10014004</ctepCode>
				<otherRequired>true</otherRequired>
				<CtcCategory>
					<id>302</id>
					<name>AUDITORY/EAR</name>
				</CtcCategory>
			</term>
			<full-name>Auditory/Ear - Other (Specify, __)</full-name>
		</AdverseEventCtcTerm>
		<AdverseEventMeddraLowLevelTerm/>
		<LowLevelTerm>
			<id>10105116</id>
			<meddraCode>10043882</meddraCode>
			<meddraTerm>Tinnitus</meddraTerm>
			<fullName>10043882 - Tinnitus</fullName>
		</LowLevelTerm>
		<attributionSummary xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">3: Possible</attributionSummary>
		<grade xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">2: Moderate</grade>
		<hospitalization xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">2: No</hospitalization>
		<eventApproximateTime>
			<type>0</type>
		</eventApproximateTime>
	</AdverseEvent>
	<AdverseEvent>
		<gridId>PRN1012106d-94b3-43ca-8498-cd7c296401f9</gridId>
		<detailsForOther>test verbatim</detailsForOther>
		<expected>false</expected>
		<CourseAgentAttribution>
			<id>430</id>
			<attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">2: Unlikely</attribution>
			<CourseAgent>
				<id>82</id>
				<lastAdministeredDate>2008-12-01T00:00:00.000-05:00</lastAdministeredDate>
				<Dose>
					<amount>100</amount>
					<units>mg</units>
				</Dose>
				<StudyAgent>
					<Agent>
						<id>443</id>
						<name>Alvocidib (flavopiridol)</name>
						<nscNumber>649890</nscNumber>
					</Agent>
					<INDType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">CTEP_IND</INDType>
				</StudyAgent>
			</CourseAgent>
		</CourseAgentAttribution>
		<CourseAgentAttribution>
			<id>431</id>
			<attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">4: Probable</attribution>
			<CourseAgent>
				<id>83</id>
				<lastAdministeredDate>2008-12-04T00:00:00.000-05:00</lastAdministeredDate>
				<Dose>
					<amount>60</amount>
					<units>mg</units>
				</Dose>
				<StudyAgent>
					<Agent>
						<id>240</id>
						<name>CISplatin</name>
						<nscNumber>119875</nscNumber>
					</Agent>
					<INDType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">NA_COMMERCIAL</INDType>
				</StudyAgent>
			</CourseAgent>
		</CourseAgentAttribution>
		<DiseaseAttribution>
			<id>432</id>
			<attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">1: Unrelated</attribution>
			<DiseaseHistory>
				<id>79</id>
				<diagnosisDate>
					<monthString>10</monthString>
					<yearString>2006</yearString>
				</diagnosisDate>
				<CtepStudyDisease>
					<id>57</id>
					<leadDisease>false</leadDisease>
					<DiseaseTerm>
						<id>204</id>
						<term>Primary peritoneal carcinoma</term>
						<ctepTerm>Primary peritoneal carcinoma</ctepTerm>
						<DiseaseCategory>
							<id>104</id>
							<name>Ovarian Cancer (excluding Ovarian Germ Cell Cancer)</name>
						</DiseaseCategory>
					</DiseaseTerm>
				</CtepStudyDisease>
				<AnatomicSite>
					<id>39</id>
					<name>Ovary</name>
					<category>Genitourinary</category>
				</AnatomicSite>
			</DiseaseHistory>
		</DiseaseAttribution>
		<AdverseEventCtcTerm other-required="true" med-dRA="false">
			<ctc-term>
				<id>3003</id>
				<term>Allergy/Immunology - Other (Specify, __)</term>
				<ctepTerm>Immune system disorder</ctepTerm>
				<ctepCode>10021425</ctepCode>
				<otherRequired>true</otherRequired>
				<CtcCategory>
					<id>301</id>
					<name>ALLERGY/IMMUNOLOGY</name>
				</CtcCategory>
			</ctc-term>
			<universal-term>Allergy/Immunology - Other: test verbatim</universal-term>
			<term xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="CtcTerm">
				<id>3003</id>
				<term>Allergy/Immunology - Other (Specify, __)</term>
				<ctepTerm>Immune system disorder</ctepTerm>
				<ctepCode>10021425</ctepCode>
				<otherRequired>true</otherRequired>
				<CtcCategory>
					<id>301</id>
					<name>ALLERGY/IMMUNOLOGY</name>
				</CtcCategory>
			</term>
			<full-name>Allergy/Immunology - Other (Specify, __)</full-name>
		</AdverseEventCtcTerm>
		<AdverseEventMeddraLowLevelTerm/>
		<attributionSummary xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">1: Unrelated</attributionSummary>
		<grade xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">3: Severe</grade>
		<hospitalization xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">1: Yes</hospitalization>
		<eventApproximateTime>
			<type>0</type>
		</eventApproximateTime>
		<Outcome>
			<id>262</id>
			<OutcomeType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">HOSPITALIZATION</OutcomeType>
		</Outcome>
	</AdverseEvent>
	<SAEReportPriorTherapy>
		<id>111</id>
		<PriorTherapy>
			<id>17</id>
			<text>Surgery</text>
			<meddraTerm>10042609</meddraTerm>
			<meddraCode>Surgery</meddraCode>
		</PriorTherapy>
		<other>resection</other>
		<startDate>
			<monthString>10</monthString>
			<yearString>2006</yearString>
		</startDate>
		<endDate>
			<monthString>10</monthString>
			<yearString>2006</yearString>
		</endDate>
	</SAEReportPriorTherapy>
	<Summary id="Participant">
		<value>Pat Little (PL-113)</value>
	</Summary>
	<Summary id="Study">
		<value>Phase II Trial of Flavopiridol and Cisplatin in Advanced Epithelial Ovarian and Primary Peritoneal Carcinomas (5876)</value>
	</Summary>
	<Summary id="Report created at">
		<value>2009-02-23 11:30:19.916</value>
	</Summary>
	<Summary id="Primary AE">
		<value>Dry skin</value>
	</Summary>
	<Summary id="AE count">
		<value>6</value>
	</Summary>
	<Summary id="Public identifier">
		<value>MD017-MD017</value>
	</Summary>
	<Summary id="Ticket number"/>
	<Summary id="Next report due"/>
	<Summary id="Course">
		<value/>
	</Summary>
	<TreatmentInformation>
		<firstCourseDate>2008-12-01T00:00:00.000-05:00</firstCourseDate>
		<investigationalAgentAdministered>false</investigationalAgentAdministered>
		<TreatmentAssignment>
			<code>A</code>
			<description>(Cycle= 3 Weeks): Cisplatin 60 mg/m2 IV on day 1 Flavopiridol 100 mg/m2 CIV over 24 hours on day 1</description>
		</TreatmentAssignment>
		<totalCourses>1</totalCourses>
		<AdverseEventCourse>
			<number>1</number>
			<date>2008-12-01T00:00:00.000-05:00</date>
		</AdverseEventCourse>
		<CourseAgent>
			<id>82</id>
			<lastAdministeredDate>2008-12-01T00:00:00.000-05:00</lastAdministeredDate>
			<Dose>
				<amount>100</amount>
				<units>mg</units>
			</Dose>
			<StudyAgent>
				<Agent>
					<id>443</id>
					<name>Alvocidib (flavopiridol)</name>
					<nscNumber>649890</nscNumber>
				</Agent>
				<INDType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">CTEP_IND</INDType>
			</StudyAgent>
		</CourseAgent>
		<CourseAgent>
			<id>83</id>
			<lastAdministeredDate>2008-12-04T00:00:00.000-05:00</lastAdministeredDate>
			<Dose>
				<amount>60</amount>
				<units>mg</units>
			</Dose>
			<StudyAgent>
				<Agent>
					<id>240</id>
					<name>CISplatin</name>
					<nscNumber>119875</nscNumber>
				</Agent>
				<INDType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">NA_COMMERCIAL</INDType>
			</StudyAgent>
		</CourseAgent>
	</TreatmentInformation>
	<AdditionalInformation>
		<id>79</id>
		<autopsyReport>false</autopsyReport>
		<consults>false</consults>
		<dischargeSummary>false</dischargeSummary>
		<flowCharts>false</flowCharts>
		<labReports>false</labReports>
		<obaForm>false</obaForm>
		<other>false</other>
		<pathologyReport>true</pathologyReport>
		<progressNotes>true</progressNotes>
		<radiologyReports>false</radiologyReports>
		<referralLetters>false</referralLetters>
		<irbReport>false</irbReport>
	</AdditionalInformation>
		<Report>
		<ReportDefinition>
			<duration>1</duration>
			<timeScaleUnitType xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">DAY</timeScaleUnitType>
		</ReportDefinition>		
	</Report>
</AdverseEventReport>